Thursday, November 26, 2015

Temple sets up office at University City Science Center

Temple wants to generate more money from scientific entrepreneurial ventures that it helps to launch, so it established an office at the University City Science Center.

Temple sets up office at University City Science Center


Universities of all sorts are looking for revenue to pay staff and keep tuition affordable, and Temple is trying to generate more money from scientific entrepreneurial ventures that it helps to launch.

To that end, Temple established an office at the University City Science Center to help fledgling companies gain profitable traction.

"These for-profit companies need space to grow and it doesn't always work in an academic space," said Tony Lowman, a bioengineering professor and university vice provost for research and business development. "Stephen Tang has done a phenomenal job in making that a place to be for companies getting started."

Tang is the Science Center chief executive officer. Lowman serves on the Science Center's scientific advisory board. Lowman joined Temple seven months ago after working at Drexel and launched his own start-up from the Science Center.

More coverage
NextFab helps designers build their dream gadgets

The Science Center has IT access, space for meetings and laboratories of several sorts. As important, it creates connections between those mixing potions or wires and venture capitalists and other business entrepreneurs who might invest in a company. Even if the project is not ready for incorporation, Lowman said, ideas can be vetted.

"This is our starting point," Lowman said. "I hope to eventually see a whole wing of Temple start-ups."

Temple will pay the rent for the space at the Science Center and will cover its costs through licensing agreements with companies. Temple has several formulas for sharing costs and royalties with faculty, staff and students who generate ideas that become profitable. And because few things in life are guaranteed, Temple's Science Center projects will have a "graduation date," defined by Temple, by which the company needs to have shown sufficient progress.

Lowman said that a few years ago Temple generated only $200,000 to $300,000 in annual royalty revenue, but greater emphasis has paid off. Temple brought in $1.3 million for the fiscal (and academic) year that ended June 30, 2011, Lowman said, and the school already has $2.7 million in revenue for the current year.

"This is a great example of how regional collaboration can help grow companies and create jobs, while enhancing Greater Philadelphia's reputation as a technology commercialization hub," Tang said in a statement. "We're honored that Temple chose the Science Center to establish its first presence in an incubator, and we're delighted to play a role in the commercialization of technologies coming out of the university."

Inquirer Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at or 215-854-4506.

David Sell Inquirer Staff Writer
Also on
letter icon Newsletter